Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings.
Kumarasamy N, Madhavan V, Venkatesh KK, Saravanan S, Kantor R, Balakrishnan P, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Mayer KH, Benson C, Schooley R. Kumarasamy N, et al. Among authors: madhavan v. Clin Infect Dis. 2009 Jul 15;49(2):306-9. doi: 10.1086/600044. Clin Infect Dis. 2009. PMID: 19522657 Free PMC article.
Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings.
Iqbal HS, Balakrishnan P, Cecelia AJ, Solomon S, Kumarasamy N, Madhavan V, Murugavel KG, Ganesh AK, Solomon SS, Mayer KH, Crowe SM. Iqbal HS, et al. Among authors: madhavan v. J Med Microbiol. 2007 Dec;56(Pt 12):1611-1614. doi: 10.1099/jmm.0.47456-0. J Med Microbiol. 2007. PMID: 18033828
Unusual insertion and deletion at codon 67 and 69 of HIV type 1 subtype C reverse transcriptase among first-line highly active antiretroviral treatment-failing South Indian patients: association with other resistance mutations.
Saravanan S, Madhavan V, Kantor R, Sivamalar S, Gomathi S, Solomon SS, Kumarasamy N, Smith DM, Schooley RT, Solomon S, Balakrishnan P. Saravanan S, et al. Among authors: madhavan v. AIDS Res Hum Retroviruses. 2012 Dec;28(12):1763-5. doi: 10.1089/AID.2011.0331. Epub 2012 May 21. AIDS Res Hum Retroviruses. 2012. PMID: 22404052 Free PMC article.
Darunavir is a good third-line antiretroviral agent for HIV type 1-infected patients failing second-line protease inhibitor-based regimens in South India.
Saravanan S, Madhavan V, Balakrishnan P, Smith DM, Solomon SS, Sivamalar S, Poongulali S, Kumarasamy N, Schooley RT, Solomon S, Kantor R. Saravanan S, et al. Among authors: madhavan v. AIDS Res Hum Retroviruses. 2013 Mar;29(3):630-2. doi: 10.1089/AID.2011.0334. Epub 2012 Dec 7. AIDS Res Hum Retroviruses. 2013. PMID: 23045961 Free PMC article.
Analysis of selection pressure and mutational pattern of HIV type 1 reverse transcriptase region among treated and nontreated patients.
Shanmugasundaram U, Solomon S, Madhavan V, Kailapuri MG, Nagalingeswaran K, Solomon SS, Mayer KH, Pachamuthu B. Shanmugasundaram U, et al. Among authors: madhavan v. AIDS Res Hum Retroviruses. 2010 Oct;26(10):1093-6. doi: 10.1089/aid.2009.0300. Epub 2010 Sep 19. AIDS Res Hum Retroviruses. 2010. PMID: 20849301 Free PMC article.
High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.
Saravanan S, Madhavan V, Velu V, Murugavel KG, Waldrop G, Solomon SS, Balakrishnan P, Kumarasamy N, Smith DM, Mayer KH, Solomon S, Thyagarajan SP. Saravanan S, et al. Among authors: madhavan v. J Int Assoc Provid AIDS Care. 2014 Jan-Feb;13(1):85-90. doi: 10.1177/2325957413488166. Epub 2013 May 30. J Int Assoc Provid AIDS Care. 2014. PMID: 23722085 Free PMC article.
The association between HIV-1 subtype C antiretroviral resistance and HLA prevalence in southern India.
Saravanan S, Madhavan V, Murugavel KG, Balakrishnan P, Solomon SS, Umapathy S, Kantor R, Kumarasamy N, Yepthomi T, Smith DM, Mayer KH, Solomon S. Saravanan S, et al. Among authors: madhavan v. J Acquir Immune Defic Syndr. 2011 May 1;57(1):e17-9. doi: 10.1097/QAI.0b013e3182169050. J Acquir Immune Defic Syndr. 2011. PMID: 21775932 Free PMC article. No abstract available.
107 results